Evidence map›Paper›PMID 40020044›Full record

ReviewJMIR public health and surveillance2025

Recent Use of Novel Data Streams During Foodborne Illness Cluster Investigations by the United States Food and Drug Administration: Qualitative Review.

Michael C Bazaco, Christina K Carstens, Tiffany Greenlee, Tyann Blessington, Evelyn Pereira, Sharon Seelman, Stranjae Ivory, Temesgen Jemaneh, Margaret Kirchner, Alvin Crosby and 14 more

Abstract readReview
In one paragraph

Review in JMIR public health and surveillance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Michael C BazacoUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0003-3155-4068
Christina K CarstensUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0002-1882-2155
Tiffany GreenleeUS Food and Drug Administration, College Park, MD, United States.ORCID 0009-0006-4490-0934
Tyann BlessingtonUS Food and Drug Administration, College Park, MD, United States.ORCID 0009-0009-7647-2040
Evelyn PereiraUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0002-3672-4954
Sharon SeelmanUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0001-8788-1485
Stranjae IvoryUS Food and Drug Administration, College Park, MD, United States.ORCID 0009-0001-4165-4065
Temesgen JemanehUS Food and Drug Administration, College Park, MD, United States.ORCID 0009-0001-1078-0042
Margaret KirchnerUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0001-5888-8610
Alvin CrosbyUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0002-1616-3926
Stelios ViazisUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0002-4711-1520
Sheila van TwuyverUS Food and Drug Administration, Minneapolis, MN, United States.ORCID 0009-0004-7657-3785
Michael GwathmeyUS Food and Drug Administration, Silver Spring, MD, United States.ORCID 0009-0000-4491-2819
Tanya MalaisUS Food and Drug Administration, Silver Spring, MD, United States.ORCID 0009-0002-7877-0606
Oliver OuUS Food and Drug Administration, College Park, MD, United States.ORCID 0009-0005-9268-4757
Stephanie KenezUS Food and Drug Administration, College Park, MD, United States.ORCID 0009-0003-7858-8676
Nichole NolanUS Food and Drug Administration, College Park, MD, United States.ORCID 0009-0007-3896-8083
Andrew KarasickUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0002-2088-6748
Cecile PunzalanUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0002-3098-5897
Colin SchwensohnUS Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-5858-2889
Laura GieraltowskiUS Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-0575-4579
Cary Chen ParkerUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0001-8626-0329
Erin JenkinsUS Food and Drug Administration, College Park, MD, United States.ORCID 0000-0002-7774-2438
Stic HarrisUS Food and Drug Administration, College Park, MD, United States.ORCID 0009-0000-2029-5916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: Foodborne illness is a continuous public health risk. The recognition of signals indicating a cluster of foodborne illness is key to the detection, mitigation, and prevention of foodborne adverse event incidents and outbreaks. With increased internet availability and access, novel data streams (NDSs) for foodborne illness reports initiated by users outside of the traditional public health framework have emerged. These include, but are not limited to, social media websites, web-based product reviews posted to retailer websites, and private companies that host public-generated notices of foodborne illnesses. Information gathered by these platforms can help identify early signals of foodborne illness clusters or help inform ongoing public health investigations. Here we present an overview of NDSs and 3 investigations of foodborne illness incidents by the US Food and Drug Administration that included the use of NDSs at various stages. Each example demonstrates how these data were collected, integrated into traditional data sources, and used to inform the investigation. NDSs present a unique opportunity for public health agencies to identify clusters that may not have been identified otherwise, due to new or unique etiologies, as shown in the 3 examples. Clusters may also be identified earlier than they would have been through traditional sources. NDSs can further provide investigators supplemental information that may help confirm or rule out a source of illness. However, data collected from NDSs are often incomplete and lack critical details for investigators, such as product information (eg, lot numbers), clinical or medical details (eg, laboratory results of affected individuals), and contact information for report follow-up. In the future, public health agencies may wish to standardize an approach to maximize the potential of NDSs to catalyze and supplement adverse event investigations. Additionally, the collection of essential data elements by NDS platforms and data-sharing processes with public health agencies may aid in the investigation of foodborne illness clusters and inform subsequent public health and regulatory actions.

Indexed as

Disease OutbreaksFoodborne DiseasesCluster AnalysisHumansQualitative ResearchUnited StatesUnited States Food and Drug Administrationclusterepidemiologyfoodbornefoodborne illnessfoodborne illness surveillanceillnessnovel datanovel data streamsoutbreak investigationsoutbreakspreventionproduct informationproduct reviewpublic healthsocial mediasurveillanceUnited States

Identifiers

PMID40020044
PMCPMC11887934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.